000 01672 a2200457 4500
005 20250517153142.0
264 0 _c20170705
008 201707s 0 0 eng d
022 _a1083-351X
024 7 _a10.1074/jbc.M117.792192
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSanders, Matthew A
245 0 0 _aPharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs.
_h[electronic resource]
260 _bThe Journal of biological chemistry
_c06 2017
300 _a10347-10363 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCell Line, Tumor
650 0 4 _aColonic Neoplasms
_xdrug therapy
650 0 4 _aDNA Repair
_xdrug effects
650 0 4 _aDNA Replication
_xdrug effects
650 0 4 _aDNA, Neoplasm
_xbiosynthesis
650 0 4 _aDrug Resistance, Neoplasm
_xdrug effects
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aNeoplasm Proteins
_xantagonists & inhibitors
650 0 4 _aOrganoplatinum Compounds
_xpharmacology
650 0 4 _aOxaliplatin
650 0 4 _aUbiquitin-Conjugating Enzymes
_xantagonists & inhibitors
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aHaynes, Brittany
700 1 _aNangia-Makker, Pratima
700 1 _aPolin, Lisa A
700 1 _aShekhar, Malathy P
773 0 _tThe Journal of biological chemistry
_gvol. 292
_gno. 25
_gp. 10347-10363
856 4 0 _uhttps://doi.org/10.1074/jbc.M117.792192
_zAvailable from publisher's website
999 _c27160038
_d27160038